HCA Healthcare, Inc. $HCA Holdings Reduced by Illinois Municipal Retirement Fund

Illinois Municipal Retirement Fund decreased its stake in shares of HCA Healthcare, Inc. (NYSE:HCA) by 11.6% in the 3rd quarter, HoldingsChannel.com reports. The institutional investor owned 15,868 shares of the company’s stock after selling 2,090 shares during the quarter. Illinois Municipal Retirement Fund’s holdings in HCA Healthcare were worth $6,772,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also made changes to their positions in HCA. MidFirst Bank acquired a new stake in shares of HCA Healthcare during the second quarter valued at $28,000. Clearstead Trust LLC acquired a new position in HCA Healthcare in the 2nd quarter valued at about $29,000. Latitude Advisors LLC purchased a new position in HCA Healthcare in the 3rd quarter valued at about $32,000. Delos Wealth Advisors LLC purchased a new position in HCA Healthcare in the 2nd quarter valued at about $35,000. Finally, Laurel Wealth Advisors LLC acquired a new stake in shares of HCA Healthcare during the 3rd quarter worth about $40,000. 62.73% of the stock is currently owned by hedge funds and other institutional investors.

HCA Healthcare Stock Down 1.1%

NYSE:HCA opened at $500.59 on Friday. The company has a market cap of $104.57 billion, a P/E ratio of 16.59, a P/E/G ratio of 1.69 and a beta of 1.11. The firm’s 50 day moving average is $451.01 and its two-hundred day moving average is $445.95. HCA Healthcare, Inc. has a fifty-two week low of $353.99 and a fifty-two week high of $556.52.

HCA Healthcare (NYSE:HCA) last announced its quarterly earnings data on Tuesday, October 27th. The company reported $7.22 earnings per share (EPS) for the quarter, beating the consensus estimate of $6.65 by $0.57. The company had revenue of $19.85 billion during the quarter, compared to analysts’ expectations of $19.33 billion. HCA Healthcare had a net margin of 8.61% and a negative return on equity of 198.52%. The business’s quarterly revenue was up 3.6% compared to the same quarter last year. During the same period in the previous year, the company earned $6.96 EPS. Research analysts forecast that HCA Healthcare, Inc. will post 30.15 earnings per share for the current fiscal year.

HCA Healthcare Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Tuesday, December 29th. Shareholders of record on Tuesday, December 15th will be given a dividend of $0.78 per share. This represents a $3.12 dividend on an annualized basis and a yield of 0.6%. The ex-dividend date of this dividend is Tuesday, December 15th. HCA Healthcare’s payout ratio is 10.34%.

Insider Buying and Selling at HCA Healthcare

In other HCA Healthcare news, EVP Michael Schlosser sold 1,200 shares of the company’s stock in a transaction dated Wednesday, November 4th. The stock was sold at an average price of $494.65, for a total transaction of $593,580.00. Following the completion of the sale, the executive vice president directly owned 1,443 shares in the company, valued at $713,779.95. This represents a 45.40% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, SVP Erica Rossitto sold 3,500 shares of the firm’s stock in a transaction dated Tuesday, November 10th. The stock was sold at an average price of $505.81, for a total value of $1,770,335.00. Following the completion of the transaction, the senior vice president owned 13,426 shares in the company, valued at approximately $6,791,005.06. This trade represents a 20.68% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Over the last 90 days, insiders sold 36,413 shares of company stock valued at $18,251,464. Company insiders own 1.50% of the company’s stock.

Wall Street Analyst Weigh In

HCA has been the subject of several recent analyst reports. Bank of America lifted their target price on shares of HCA Healthcare from $450.00 to $500.00 and gave the stock a “neutral” rating in a research note on Wednesday, October 28th. Royal Bank Of Canada increased their price target on HCA Healthcare from $496.00 to $521.00 and gave the stock an “outperform” rating in a research note on Friday, October 30th. Truist Financial reaffirmed a “buy” rating and issued a $510.00 price objective (up from $495.00) on shares of HCA Healthcare in a research report on Tuesday, November 3rd. Wall Street Zen upgraded HCA Healthcare from a “hold” rating to a “buy” rating in a research report on Saturday, October 31st. Finally, Wells Fargo & Company raised their price target on HCA Healthcare from $381.00 to $468.00 and gave the stock an “equal weight” rating in a research note on Monday, November 2nd. Sixteen analysts have rated the stock with a Buy rating, seven have given a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus price target of $480.13.

About HCA Healthcare

HCA Healthcare is a healthcare services company that operates hospitals and other care facilities. Its services include inpatient and outpatient care, emergency treatment, surgery, diagnostic services and specialized care across areas such as cancer and cardiovascular medicine. The company serves patients in the United States and the United Kingdom through its network of hospitals and outpatient facilities, including surgery centers, urgent care clinics and physician practices. Founded in 1968, HCA Healthcare is headquartered in Nashville, Tennessee.